Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
46 participants
OBSERVATIONAL
2014-07-31
2015-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Reliability of Different FOT Devices to Measure the Human Respiratory Impedance
NCT01868607
Investigation of Heart Failure Status Over Time Using Respiratory Parameters
NCT00494117
Evaluation of MRI Measures of Lung Water With Posture Changes in Healthy Volunteers and in Patients With Cardiac Failure
NCT01277679
Not Invasive Monitoring of Pleural Drainage
NCT01778270
Electrical Impedance Tomography for Quantification of Pulmonary Edema in Acute Respiratory Distress Syndrome Patients
NCT02870894
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
IMED-4
Non invasive recording electrode used to assess lung fluid
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
1. PCWP \>25mmHg
2. Dyspnea at rest in a recumbent sitting position (30 to 45 degrees), which has worsened within the past week
3. Radiological evidence of CHF on a chest X-ray
4. Physical exam as evidence for pulmonary congestion:
i. Presence of an S3 heart sound ii. Lung rales/crackles/crepitations
2. Age greater than or equal to (≥) 18
3. Ability to reliably carry out self-assessment of symptoms
4. Willingness, ability and commitment to participate in index and follow-up IMED-4 recordings
Exclusion Criteria
2. Clinical diagnosis of acute coronary syndrome meeting any 2 of the following 3 criteria:
1. Prolonged chest pain at rest, or an accelerated pattern of angina
2. Electrocardiogram changes indicative of ischemia or myocardial injury
3. Serum troponin \>3 times upper limit of lab normal
3. Clinically-suspected acute mechanical cause of ADHF (e.g., papillary muscular rupture); the diagnosis need not be confirmed by imaging or cardiac catheterization
4. Estimated Glomerular Filtration Rate: eGFR \<30mL/min/1.73m
5. Known vasculitis, active infective endocarditis, or suspected infections including pneumonia, acute hepatitis, systemic inflammatory response syndrome, or sepsis
6. Body temperature ≥38°C just prior to enrollment
7. Acute or chronic respiratory disorder (e.g. severe chronic obstructive pulmonary disease (COPD)) or primary pulmonary hypertension sufficient to cause dyspnea at rest, which may interfere with the ability to interpret dyspnea assessments or hemodynamic measurements
8. Total Albumin \<2.5 g/dL
9. Patients requiring mechanical circulatory support
10. Pregnancy or lactation
11. Patients who have tattoos and/or non-intact skin directly under the electrode sensor position
12. Patients who have had past allergic reactions to medical grade adhesives
13. Patients who have had a lung lobectomy
14. Patients who decline to have their backs photographed with the IMED-4 device in position
15. Severe co-morbidity or poor general physical/mental health that, in the opinion of the Investigator, will not allow the subject to be a good study candidate (i.e. other disease processes, mental capacity, substance abuse, incarceration, shortened life expectance, etc.)
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Intersection Medical, Inc.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Mass General Hospital
Boston, Massachusetts, United States
Henry Ford Hospital
Detroit, Michigan, United States
Ohio State University
Columbus, Ohio, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CP-000040
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.